Neuromyelitis Optica Spectrum Disorder Following COVID-19 Infection with Increase in Pre-existing Anti-aquaporin-4 Antibodies

Overview

Journal J Neurol

Specialty Neurology

Date 2022 Jan 22

PMID 35064812

Authors

Alexandre Jentzer

Clarisse Carra-Dalliere

Claire Lozano

Sophie Riviere

Olivier Darmon

Xavier Ayrignac

Pierre Labauge

Thierry Vincent

Affiliations

Soon will be listed here.

Citing Articles

New onset or relapsing neuromyelitis optica temporally associated with SARS-CoV-2 infection and COVID-19 vaccination: a systematic review.

Harel T, Gorman E, Wallin M Front Neurol. 2023; 14:1099758.

PMID: 37426444 PMC: 10323143. DOI: 10.3389/fneur.2023.1099758.

COVID-19 and the risk of CNS demyelinating diseases: A systematic review.

Lotan I, Nishiyama S, Manzano G, Lydston M, Levy M Front Neurol. 2022; 13:970383.

PMID: 36203986 PMC: 9530047. DOI: 10.3389/fneur.2022.970383.

[Manifestations of the central nervous system after COVID-19].

Gerhard A, Pruss H, Franke C Nervenarzt. 2022; 93(8):769-778.

PMID: 35552466 PMC: 9096778. DOI: 10.1007/s00115-022-01294-2.

References

Ibrahim Ismail I, Salama S . Association of CNS demyelination and COVID-19 infection: an updated systematic review. J Neurol. 2021; 269(2):541-576. PMC: 8359762. DOI: 10.1007/s00415-021-10752-x. View